Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats - PubMed
. 2009 Apr;203(2):203-11.
doi: 10.1007/s00213-008-1458-3. Epub 2009 Jan 20.
Affiliations
- PMID: 19153716
- DOI: 10.1007/s00213-008-1458-3
Comparison of the discriminative stimulus effects of salvinorin A and its derivatives to U69,593 and U50,488 in rats
Lisa E Baker et al. Psychopharmacology (Berl). 2009 Apr.
Abstract
Background and rationale: Research interests regarding the psychopharmacology of salvinorin A have been motivated by the recreational use and widespread media focus on the hallucinogenic plant, Salvia divinorum. Additionally, kappa opioid (KOP) receptor ligands may have therapeutic potential in the treatment of some neuropsychiatric conditions, including drug dependence and mood disorders. Salvinorin A is a selective KOP agonist, but only a few studies have explored the discriminative stimulus effects of this compound.
Objective: This study compared the discriminative stimulus effects of salvinorin A and two synthetic derivatives of salvinorin B to the KOP agonists, U69,593 and U50,488.
Materials and methods: Sixteen male Sprague-Dawley rats trained to discriminate U69,593 (0.13 mg/kg, s.c., N = 8) or U50,488 (3.0 mg/kg, i.p., N = 8) under a fixed-ratio 20 schedule of food reinforcement were administered substitution tests with salvinorin A (0.125-3.0 mg/kg, i.p.). The animals trained to discriminate U69,593 were also administered substitution tests with salvinorin B ethoxymethyl ether (0.005-0.10 mg/kg, i.p.) and salvinorin B methoxymethyl ether (0.03-0.10 mg/kg, i.p.). Another eight rats were trained to discriminate 2.0 mg/kg salvinorin A and tested with U69,593 (0.04-0.32 mg/kg) and U50,488 (0.4-3.2 mg/kg).
Results: Salvinorin A and both synthetic derivatives of salvinorin B substituted completely for U69,593. Additionally, cross-generalization was observed between salvinorin A and both KOP agonists.
Conclusion: These findings support previous reports indicating that the discriminative stimulus effects of salvinorin A are mediated by kappa receptors. Future studies may assist in the development and screening of salvinorin A analogs for potential pharmacotherapy.
Similar articles
-
Peet MM, Baker LE. Peet MM, et al. Behav Pharmacol. 2011 Sep;22(5-6):450-7. doi: 10.1097/FBP.0b013e328349fc1b. Behav Pharmacol. 2011. PMID: 21814135
-
Butelman ER, Harris TJ, Kreek MJ. Butelman ER, et al. Psychopharmacology (Berl). 2004 Mar;172(2):220-4. doi: 10.1007/s00213-003-1638-0. Epub 2003 Oct 30. Psychopharmacology (Berl). 2004. PMID: 14586540
-
Willmore-Fordham CB, Krall DM, McCurdy CR, Kinder DH. Willmore-Fordham CB, et al. Neuropharmacology. 2007 Sep;53(4):481-6. doi: 10.1016/j.neuropharm.2007.06.008. Epub 2007 Jun 27. Neuropharmacology. 2007. PMID: 17681558
-
Neuropharmacology of the naturally occurring kappa-opioid hallucinogen salvinorin A.
Cunningham CW, Rothman RB, Prisinzano TE. Cunningham CW, et al. Pharmacol Rev. 2011 Jun;63(2):316-47. doi: 10.1124/pr.110.003244. Epub 2011 Mar 28. Pharmacol Rev. 2011. PMID: 21444610 Free PMC article. Review.
-
[Salvinorin A and related diterpenes--biological activity and potential therapeutic uses].
Piekielna J, Fichna J, Janecka A. Piekielna J, et al. Postepy Biochem. 2012;58(4):485-91. Postepy Biochem. 2012. PMID: 23662442 Review. Polish.
Cited by
-
Simpson DS, Lovell KM, Lozama A, Han N, Day VW, Dersch CM, Rothman RB, Prisinzano TE. Simpson DS, et al. Org Biomol Chem. 2009 Sep 21;7(18):3748-56. doi: 10.1039/b905148a. Epub 2009 Jul 14. Org Biomol Chem. 2009. PMID: 19707679 Free PMC article.
-
Role of kappa-opioid receptors in the effects of salvinorin A and ketamine on attention in rats.
Nemeth CL, Paine TA, Rittiner JE, Béguin C, Carroll FI, Roth BL, Cohen BM, Carlezon WA Jr. Nemeth CL, et al. Psychopharmacology (Berl). 2010 Jun;210(2):263-74. doi: 10.1007/s00213-010-1834-7. Epub 2010 Apr 1. Psychopharmacology (Berl). 2010. PMID: 20358363 Free PMC article.
-
Salvinorin A analogs and other κ-opioid receptor compounds as treatments for cocaine abuse.
Kivell BM, Ewald AW, Prisinzano TE. Kivell BM, et al. Adv Pharmacol. 2014;69:481-511. doi: 10.1016/B978-0-12-420118-7.00012-3. Adv Pharmacol. 2014. PMID: 24484985 Free PMC article. Review.
-
Brito-da-Costa AM, Dias-da-Silva D, Gomes NGM, Dinis-Oliveira RJ, Madureira-Carvalho Á. Brito-da-Costa AM, et al. Pharmaceuticals (Basel). 2021 Feb 3;14(2):116. doi: 10.3390/ph14020116. Pharmaceuticals (Basel). 2021. PMID: 33546518 Free PMC article. Review.
-
Kappa opioid mediation of cannabinoid effects of the potent hallucinogen, salvinorin A, in rodents.
Walentiny DM, Vann RE, Warner JA, King LS, Seltzman HH, Navarro HA, Twine CE Jr, Thomas BF, Gilliam AF, Gilmour BP, Carroll FI, Wiley JL. Walentiny DM, et al. Psychopharmacology (Berl). 2010 Jun;210(2):275-84. doi: 10.1007/s00213-010-1827-6. Epub 2010 Mar 31. Psychopharmacology (Berl). 2010. PMID: 20354680 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials